A INTRON- (Intron-A).

     Recombinant interferon alfa-2b, LM culture intestinal bacillus.

     Has antivirus, ummunomodulating and antitumor effects.

     When applied in multiple myeloma, Sarcoma, volosatokletochnom leukemia and other cancer diseases, and chronic hepatitis B, C and D, HIV.

     Assign usually subcutaneously, intramuscularly, or intravenously, if necessary vnutripolostno.

     In chronic hepatitis in introducing subcutaneously or intramuscularly on 5000000 IU daily or 10 million IU three times a week for at least 16 weeks.

     In chronic hepatitis C designate subcutaneously to 3 million IU three times a week for at least 18 months.

     In chronic hepatitis D impose subcutaneously for 5 million IU / m 2 daily or three times a week for 3-4 months or more.

     In chronic mieloleykoze appoint 4000000, 5000000 IU / m 2 per day, supporting 10 million doses of 500000-IU / m2.

     In multiple myeloma to enter 3000000 5000000 IU-2 times a week throughout the induction therapy.

     In Sarcoma with HIV apply to 30 million IU / m 2 daily or three times a week.

     In kidney cancer appoint 20 million IU / m 2 daily for 3 months or more.

     When ovarian cancer impose on 50000000 IU vnutribryushinno over 16 weeks.

     In malignant melanoma designate intravenously to 20 million IU / m 2 5 times a week from 4 weeks to 2 years.

     When bladder cancer impose vnutripuzyrno 30000000 50000000 IU-1 once a week for 8-12 weeks.

     Solutions are just before the introduction.

     The application offers different drug side effects : nausea, dizziness, fever, diarrhoea, mialgiya, arterial hypotension, etc.; In exchange treatment likely granulotsitopeniya, thrombocytopenia, disruption of liver disease and others.

      Product : dried powder for injection solutions in vials on 3000000, 5000000, 10000000 and 30000000 IU.

      Storage : List B. With the temperature of 2 to 8 ° C.

Materials allowed to copy only with the active hyperlink to the handbook of medicines